24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Exalenz
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:27
Israeli researchers develop AI method to speed up breast cancer MRI scans
09:56
How Chinese cars became a national security issue in Israel
09:36
Israel is not losing its growth market. It is reorganizing it.
21:45
Germany’s missile search draws attention to secretive startup Covenant
More stories
Buzz
Most popular
Daily
Weekly
1
Anduril explores Israeli expansion as defense-tech boom accelerates
2
Amdocs’ layoffs fail to halt share slide
3
Marvell CTO: "The market has finally reached the bottleneck we solve"
4
Germany’s missile search draws attention to secretive startup Covenant
5
Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR
More news
Exalenz
2 stories about Exalenz
Exalenz Bioscience Acquired for $49M
19.02.20
|
Golan Hazani
Israeli-born billionaire & biomed entrepreneur Mori Arkin sold his company for 6.10 NIS per share. Learn more on CTech!
Biomed Entrepreneur Mori Arkin Nearing Sale of Exalenz to a U.S. Company
19.02.20
|
Golan Hazani
Tel Aviv-listed Exalenz is not considered one of the serial entrepreneur’s great successes, having lost 73% of its valuation over the past five years. The current deal will see it sold at a premium of tens of percentages, according to one source
